Insights On Liquid Dose Manufacturing
-
Vaccine Journey: Bench To Market
7/19/2023
Vaccines are entering a new era. Gain insight into the market trends, projections, challenges, and potential solutions around the future of vaccine manufacturing.
-
Engineering Advances In Needle Geometry To Accommodate Viscous Biologics
2/1/2023
Explore the challenges faced in administering highly viscous biologics to patients via subcutaneous injection and how new special thin-wall needles are able to tackle them.
-
Expanding Home-Based Care With A Next-Gen On-Body Delivery System
10/20/2023
As on-body delivery systems (OBDSs) enable the shift to patient-centric treatment, manufacturers must optimize the device and therapy formulation to minimize the risks and increase adherence.
-
Gloved Vs. Gloveless Filling Machines
7/18/2023
When selecting an aseptic fill/finish machine, the choice to use a gloved or gloveless isolator will arise. To help with that decision, here are a few attributes to consider.
-
Maximize Product Recovery In Bulk Filtration And Filling Flow Paths
12/15/2022
Explore a fill system designed to automate product draining and recovery within a batch to standardize processes and minimize non-recoverable hold-up within the filtration and distribution flow path sections.
-
How To Protect A Modern Silicone Oil-Sensitive Biologic Drug For Self-Injection Of 2.25mL
4/25/2023
A customer experienced expensive project delays when they selected their “tried and tested” large volume, glass syringe system to package a drug to be used in an auto-injector for self-administration.
-
Switching From Vials To PFS And Intravenous To Subcutaneous Formulations
7/25/2023
Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.
-
Electron Activated Dissociation Workflow For Biotherapeutics Characterization
8/28/2023
Explore the benefits of an electron-activated dissociation middle-down workflow, including the ability to achieve high sequence coverages (70%-80%) of monoclonal antibody subunits in a single injection.
-
Successful Planning: Process Liquid & Buffer Preparation
6/23/2023
Obtain an accurate total cost of ownership assessment through understanding common operational inefficiencies, risks, and financial burdens associated with process liquid and buffer preparation.
-
Ensure Speed And Success With Your Drug Delivery Project
5/18/2023
Hear from experienced professionals in the drug delivery space on how to ensure success and speed-to-market by establishing a firm foundation when working with a CMO.